| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.51B | 7.21B | 6.13B | 5.50B | 5.00B | 4.39B |
| Gross Profit | 6.84B | 6.56B | 5.55B | 4.99B | 4.53B | 3.97B |
| EBITDA | 2.12B | 1.80B | 1.56B | 1.27B | 1.17B | 789.20M |
| Net Income | 1.46B | 1.12B | 1.11B | 906.00M | 823.00M | 497.00M |
Balance Sheet | ||||||
| Total Assets | 11.93B | 12.47B | 10.83B | 9.91B | 9.44B | 8.61B |
| Cash, Cash Equivalents and Short-Term Investments | 2.92B | 2.60B | 1.89B | 2.25B | 2.07B | 1.76B |
| Total Debt | 2.72B | 2.73B | 2.56B | 2.63B | 2.67B | 3.06B |
| Total Liabilities | 8.74B | 9.42B | 8.21B | 8.06B | 8.29B | 7.76B |
| Stockholders Equity | 3.19B | 3.04B | 2.62B | 1.85B | 1.15B | 849.10M |
Cash Flow | ||||||
| Free Cash Flow | 2.73B | 2.41B | 1.50B | 1.28B | 2.02B | 1.46B |
| Operating Cash Flow | 2.78B | 2.45B | 1.61B | 1.31B | 2.07B | 1.53B |
| Investing Cash Flow | -480.00M | -451.00M | -903.00M | -502.00M | -143.00M | -1.59B |
| Financing Cash Flow | -1.44B | -1.36B | -987.00M | -852.00M | -1.49B | -168.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $106.18B | 89.44 | 21.06% | ― | 13.42% | 8.47% | |
77 Outperform | $81.84B | 598.62 | 3.78% | ― | 29.54% | -21.11% | |
74 Outperform | $13.13B | 10.78 | 33.14% | ― | 27.75% | 187.41% | |
71 Outperform | $41.87B | 28.62 | 49.42% | ― | 18.88% | 46.42% | |
70 Outperform | $9.32B | 34.01 | 23.62% | 0.72% | 12.23% | 10.63% | |
62 Neutral | $22.46B | -106.55 | -16.70% | ― | 24.74% | 49.81% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |